Luís Force

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Evaluation of Eight Serological Tests in the Diagnosis of Human Echinococcosis and Follow-Up

Luís Force, J. Mestre Torres, A. Carrillo et al. · Clinical Infectious Diseases · 1992 · 126 citations

Veterinary Medicine, Infectious Diseases, Internal Medicine +11

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

Juan Berenguer, Antonio Rivero, Inmaculada Jarrín et al. · Open Forum Infectious Diseases · 2016 · 42 citations · Full text

Life Sciences, Infectious Diseases, Internal Medicine +15

Failure of a Short-Term Prednisone Regimen to Prevent Nevirapine-Associated Rash: A Double-Blind Placebo-Controlled Trial: The GESIDA 09/99 Study

Hernando Knobel, José M. Miró, Peré Domingo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 39 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Dolutegravir for the treatment of HIV-2 infection

Ana Treviño, Teresa Cabezas, Ana Belén Peinado Lozano et al. · Journal of Clinical Virology · 2015 · 38 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12